Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monte Rosa Therapeutics (GLUE) Cash from Investing Activities (2023 - 2025)

Monte Rosa Therapeutics' Cash from Investing Activities history spans 3 years, with the latest figure at -$65.1 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 110.6% year-over-year to -$65.1 million; the TTM value through Dec 2025 reached -$101.8 million, down 129.09%, while the annual FY2025 figure was -$101.8 million, 129.09% down from the prior year.
  • Cash from Investing Activities reached -$65.1 million in Q4 2025 per GLUE's latest filing, down from $38.1 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $38.1 million in Q3 2025 to a low of -$100.2 million in Q1 2025.
  • Average Cash from Investing Activities over 3 years is -$4.8 million, with a median of $16.4 million recorded in 2023.
  • The largest YoY upside for Cash from Investing Activities was 141.41% in 2025 against a maximum downside of 1117.24% in 2025.
  • A 3-year view of Cash from Investing Activities shows it stood at $14.3 million in 2023, then tumbled by 316.1% to -$30.9 million in 2024, then crashed by 110.6% to -$65.1 million in 2025.
  • Per Business Quant, the three most recent readings for GLUE's Cash from Investing Activities are -$65.1 million (Q4 2025), $38.1 million (Q3 2025), and $25.3 million (Q2 2025).